Real-time enrollment status for this sickle cell disease clinical trial
Current Status
Completed
Checked: June 2, 2026 at 1:11 AM UTC
| NCT Number | NCT05861453 |
| Recruiting Status | Completed |
| Condition | Sickle Cell Disease |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Afimmune |
| Last Updated on CT.gov | May 4, 2026 (4 weeks ago) |
As of June 2, 2026: Clinical trial NCT05861453 is currently completed participants. This clinical trial study for sickle cell disease is not currently accepting new participants at 18 locations across the United States. The study is sponsored by Afimmune. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05861453 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05861453 was last updated 4 weeks ago (May 4, 2026). HelloStudys verifies this status automatically.